{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-07-12T13%3A48%3A07.142Z&AnsweringBody.=Department+of+Health&creator.label=Biography+information+for+Jim+Dobbin", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpModified.=2019-07-12T13%3A48%3A07.142Z&AnsweringBody.=Department+of+Health&creator.label=Biography+information+for+Jim+Dobbin", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-07-12T13%3A48%3A07.142Z&AnsweringBody.=Department+of+Health&_metadata=all&creator.label=Biography+information+for+Jim+Dobbin", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpModified.=2019-07-12T13%3A48%3A07.142Z&AnsweringBody.=Department+of+Health&creator.label=Biography+information+for+Jim+Dobbin", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-07-12T13%3A48%3A07.142Z&AnsweringBody.=Department+of+Health&creator.label=Biography+information+for+Jim+Dobbin", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-07-12T13%3A48%3A07.142Z&AnsweringBody.=Department+of+Health&creator.label=Biography+information+for+Jim+Dobbin", "items" : [{"_about" : "http://data.parliament.uk/resources/90146", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/90146/answer", "answerText" : {"_value" : "
<\/p>
The latest data published by the Office for National Statistics in October 2013 shows that very few live births occur before 24 weeks gestation. Infant mortality rates for babies born this early remain extremely high. For babies born in 2011, 1 in 1000 of live births occurred at less than 24 weeks; the infant mortality rate for these babies was 894.7 deaths per 1,000 live births.<\/p>
<\/p>
<\/p>
Data from the Epicure series of studies of survival and later health among babies and young people who were born at extremely low gestations found there was no difference in the ongoing illnesses or complications affecting surviving babies born between 22 and 25 weeks gestation in 1995 and 2006. High levels of disability were present at 6 years of age in surviving children born before 24 weeks, including cerebral palsy, low cognitive scores, mobility problems, blindness or profound hearing loss.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-09-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-09-04T15:43:30.3540219Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-09-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Childbirth"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of changes in the survival rate of babies born before 24 weeks gestation; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/446", "label" : {"_value" : "Biography information for Jim Dobbin"} } , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"} , "tablingMemberPrinted" : [{"_value" : "Jim Dobbin"} ], "uin" : "207752"} , {"_about" : "http://data.parliament.uk/resources/90148", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/90148/answer", "answerText" : {"_value" : "
The Department decided that, because there is no existing universally agreed definition of genetic modification in humans, it would adopt a working definition. The definition that has been adopted is that genetic modification involves the germ-line modification of nuclear DNA (in the chromosomes) that can be passed on to future generations. We will keep this working definition under review.<\/p>
<\/p>
The proposed mitochondrial donation techniques do not constitute genetic modification.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-09-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/90148/answer/previousversion/18114", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} } , "questionFirstAnswered" : [{"_value" : "2014-09-05T14:26:49.4431834Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-09-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what his Department's policy is on categorising modification to genomic DNA in mitochondria through pronuclear transfer or maternal spindle transfer as genetic modification.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/446", "label" : {"_value" : "Biography information for Jim Dobbin"} } , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"} , "tablingMemberPrinted" : [{"_value" : "Jim Dobbin"} ], "uin" : "207754"} , {"_about" : "http://data.parliament.uk/resources/78486", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/78486/answer", "answerText" : {"_value" : "
Collection of data relating to treatments regulated by the Human Fertilisation and Embryology Act 1990, as amended, and the recording of serious adverse clinical reactions come within the statutory duties of the Human Fertilisation and Embryology Authority (HFEA).<\/p>
<\/p>
At its meeting on 9 July 2014, the HFEA agreed a new strategy for 2014-2017, which sets out its regulatory focus. Also at that meeting, the Authority members agreed to give consideration to the collection of additional data when a case of Ovarian Hyperstimulation Syndrome is reported. The HFEA will take expert scientific and medical advice on whether such data collection would be of value and on the feasibility of collecting reliable information.<\/p>
<\/p>
The papers for the meeting and an audio record of the discussions can be found on HFEA\u2019s website at:<\/p>
<\/p>
www.hfea.gov.uk/Authority-July-2014.html<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-09-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-09-01T14:21:07.6961331Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-07-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ovarian Hyperstimulation Syndrome"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answers of 9 July 2014, Official Report, column 313W, on ovarian cancer and 24 June 2014, Official Report, columns 156-7W, on ovarian hyperstimulation syndrome, if his Department will collect data on the number of women admitted to hospital with ovarian hyperstimulation syndrome (OHSS); if he will take steps to ensure systematic reporting of OHSS from egg sharing and egg donation; if he will make it his policy that ovarian hyperstimulation syndrome be notifiable; and if he will take steps to ensure that women are accurately informed of the risk of hospitalisation from OHSS when considering egg donation or egg sharing procedures.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/446", "label" : {"_value" : "Biography information for Jim Dobbin"} } , "tablingMemberConstituency" : {"_value" : "Heywood and Middleton"} , "tablingMemberPrinted" : [{"_value" : "Jim Dobbin"} ], "uin" : "206103"} , {"_about" : "http://data.parliament.uk/resources/77641", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77641/answer", "answerText" : {"_value" : "
The Human Fertilisation and Embryology Authority (HFEA) has advised that research licence R0152 was renewed in May 2014. The inspection report and minutes which set out the use to which materials were put under that licence are available on the HFEA\u2019s website at:<\/p>
<\/p>